New research on fillers and non-surgical aesthetics after GLP-1 weight loss
- Allergan Aesthetics (AbbVie) presented 9 abstracts at ASDS 2026 in San Diego (5–8 November).
- Two Phase 4 studies looked at hyaluronic acid fillers and multimodal treatment after GLP-1 weight loss.
- The studies assessed patient satisfaction and psychosocial outcomes.
- Other abstracts compared two botulinum toxins and covered exosome serums.
Allergan Aesthetics, an AbbVie company, announced 9 abstracts for the American Society for Dermatologic Surgery meeting (ASDS 2026) in San Diego, 5–8 November 2026.
Aesthetics after GLP-1 weight loss
The headline work is two Phase 4 studies in people who lost weight with GLP-1 medicines. They evaluated hyaluronic acid fillers and multimodal aesthetic treatment for patient satisfaction and psychosocial outcomes, as more people report loss of facial volume after rapid weight loss.
Also read: Study: US rules on Botox and filler injections vary widely by state, and some states have none
Other research
- A comparison of the new toxin TrenibotE with BOTOX Cosmetic showed similar clinical outcomes.
- Abstracts on exosome serums for skin care.
The announcement did not include detailed results, so full conclusions await publication.
Source: AbbVie (Allergan Aesthetics)
This story is relayed from the source named above; responsibility for its content rests with the original source.
FAQ
What did Allergan Aesthetics present at ASDS 2026?
Allergan Aesthetics presented 9 abstracts at ASDS 2026, including two studies on aesthetics after GLP-1 weight loss.
Why might people who lose weight on GLP-1 drugs want fillers?
Some people who lose weight quickly on GLP-1 drugs lose facial volume, and hyaluronic acid fillers are one way to restore it.
What did the GLP-1 aesthetics studies measure?
Allergan's GLP-1 studies measured patient satisfaction with fillers and multimodal treatment and psychosocial outcomes.
How did TrenibotE compare with BOTOX Cosmetic?
According to Allergan Aesthetics, TrenibotE and BOTOX Cosmetic showed similar clinical outcomes.
When and where was ASDS 2026?
ASDS 2026, the American Society for Dermatologic Surgery meeting, was held in San Diego on 5–8 November 2026.



